[Distribution features of Gleason score and its relationship with clinical stages in 346 prostate cancer patients].
Shuo Wang(Shenyang Pharmaceutical University), Xinru Yu(Ningbo University), Liping Xie(First Affiliated Hospital Zhejiang University), Zhigen Zhang(Zhejiang University), Guoping Ren(Capital Medical University), Lijun Wang(National Center for Chronic and Noncommunicable Disease Control and Prevention), Jie Qin, Zhang Chen-guang, Yu Bai(Qingdao University), Huafeng Shen(First Affiliated Hospital Zhejiang University), Zhao-Dian Chen, Song-Liang Cai, Xiangyi Zheng(Tianjin University)
PubMed
August 1, 2006
Cited by 1
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276